{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ12752",
      "entity_text" : "MLL-AF9",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ12740",
      "entity_text" : "NF-kappaB-inducing kinase",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In two independent leukemia studies, expression of TIFAB was reduced upon treatment with the bromo-domain inhibitor JQ1 in acquired resistant MLL-AF9; KRas-G12D leukemia cells and following suppression of MLL-AF9 leukemic stem cells by the NF-kappaB-inducing kinase (NIK).",
  "reading_complete" : "2020-08-08T15:03:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:59:42Z",
  "trigger" : "suppression",
  "evidence" : [ "suppression of MLL-AF9 leukemic stem cells by the NF-kappaB-inducing kinase" ],
  "pmc_id" : "7384867",
  "score" : 0
}